STAGE IIB RECTAL CANCER AJCC V8
Clinical trials for STAGE IIB RECTAL CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB RECTAL CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IIB RECTAL CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested to shrink rectal tumors before surgery
Disease control OngoingThis early-stage study aims to find the safest dose of the chemotherapy drug TAS-102 when given alongside radiation therapy to patients with stage II or III rectal cancer. The goal is to shrink the tumor before the patient undergoes standard surgery and follow-up chemotherapy. Re…
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Phase: PHASE1 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Cancer's hidden cost: study reveals Treatment's financial toll on patients
Knowledge-focused OngoingThis study aims to understand the financial burden experienced by patients undergoing treatment for early-stage colon or rectal cancer. Researchers are following 565 patients for two years, asking them to complete surveys about treatment costs, employment changes, and quality of …
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Apr 04, 2026 02:06 UTC
-
Tracking life after rectal cancer: how surgery affects daily living
Knowledge-focused TerminatedThis study aims to understand how rectal cancer surgery affects patients' quality of life over time. Researchers will follow 430 patients for up to 5 years after their surgery, asking them to complete questionnaires about their daily experiences. The goal is to gather information…
Matched conditions: STAGE IIB RECTAL CANCER AJCC V8
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC